Log In
BCIQ
Print this Print this
 

Cravit, levofloxacin (oral Cravit)

  Manage Alerts
Collapse Summary General Information
Company Daiichi Sankyo Co. Ltd.
DescriptionSynthetic broad-spectrum oral fluoroquinolone antibiotic targeting bacterial DNA gyrase and topoisomerase
Molecular Target DNA gyrase ; Topoisomerase
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/02/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today